Fig. 1From: Proteomics of prostate cancer serum and plasma using low and high throughput approachesOptimized workflow for global deep profiling of plasma and serum (A) Overview of blood-based proteomics workflows for biomarker discovery (B) and (C) Key method development metrics for the DDA-TMT workflowBack to article page